Korea Accelerates AI-Driven Clinical Trial Transition, Targets Chronic Diseases
Seoul Economic Daily
Last updated: May 20, 2026
The Ministry of Health and Welfare (MOHW) is prioritizing the integration of AI and digital technologies into clinical trials. This initiative aims to enhance global competitiveness and foster innovation within the healthcare sector.
The MOHW is actively promoting the development and adoption of AI-driven tools for clinical trial design, patient recruitment, and data analysis. This strategic shift is intended to streamline trial processes and accelerate the discovery of new treatments.
Emphasis is placed on strengthening international collaborations to share best practices, harmonize regulatory frameworks, and leverage global expertise in AI and digital health. This cooperative approach is crucial for addressing complex health challenges and advancing medical research on a global scale.
The ministry is investing in infrastructure and talent development to support the digital transformation of clinical research. This includes fostering a skilled workforce capable of utilizing advanced technologies and ensuring data security and privacy standards are met.
The goal is to create a more efficient, effective, and globally integrated clinical trial ecosystem, ultimately benefiting patients through faster access to innovative therapies. This move signals a commitment to embracing cutting-edge technologies for the future of healthcare.
